These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8350783)

  • 21. Cholesterol reduction in patients with lower limb atherosclerotic disease.
    Bismuth J; Kofoed SC; Sillesen HH
    Dan Med Bull; 2002 Feb; 49(1):61-4. PubMed ID: 11894724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective management of patients with dyslipidemia.
    Lipsy RJ
    Am J Manag Care; 2003 Feb; 9(2 Suppl):S39-58. PubMed ID: 12597240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipid therapy. Goal and use in prevention of coronary heart disease].
    Windler E; Greten H
    Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925
    [No Abstract]   [Full Text] [Related]  

  • 26. Dyslipoproteinemia in the elderly. Special considerations.
    Luepker RV
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):451-62. PubMed ID: 2192881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
    Carneiro AV; Costa J; Borges M
    Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evidence of the efficacy of hypocholesterolemic treatment in primary and secondary prevention of ischemic heart disease].
    Alvarez-Sala Walther LA; Millán Núñez-Cortés J
    Med Clin (Barc); 2000; 114 Suppl 2():1-10. PubMed ID: 10916798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hypercholesterolemia.
    Blake GH; Triplett LC
    Am Fam Physician; 1995 Apr; 51(5):1157-66, 1171-2. PubMed ID: 7709892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Benefits and costs of early detection and treatment of hypercholesterolemia].
    Laaser U
    Z Kardiol; 1994; 83 Suppl 6():163-7. PubMed ID: 7863690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.
    Labreche DG
    Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850
    [No Abstract]   [Full Text] [Related]  

  • 32. Cholesterol lowering and morbidity and mortality.
    LaRosa JC
    Curr Opin Lipidol; 1995 Feb; 6(1):62-5. PubMed ID: 7735718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.
    Grundy SM; Cleeman JI; Rifkind BM; Kuller LH
    Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol management in the era of managed care.
    Grundy SM
    Am J Cardiol; 2000 Feb; 85(3A):3A-9A. PubMed ID: 10695701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In whom, when and how should increased cholesterol values be treated?].
    Greten H
    Arzneimittelforschung; 1990 Mar; 40(3A):381-3. PubMed ID: 2185770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues.
    Watts GF; Burke V
    Curr Opin Lipidol; 1996 Dec; 7(6):341-55. PubMed ID: 9117137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lowering high plasma cholesterol levels is not dangerous.
    Schwandt P; Richter WO; Sönnichsen AC
    Arch Intern Med; 1995 May; 155(9):985. PubMed ID: 7726707
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of cholesterol-lowering treatment on coronary heart disease morbidity and mortality: the evidence from trials, and beyond.
    Katan MB
    Cardiology; 1990; 77 Suppl 4():8-13. PubMed ID: 2073675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of cardiovascular morbidity and mortality in hypertension: benefits of blood pressure reduction and cholesterol lowering.
    MacMahon S
    Postgrad Med J; 1989; 65 Suppl 1():S55-7. PubMed ID: 2695910
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.
    Levine GN; Keaney JF; Vita JA
    N Engl J Med; 1995 Feb; 332(8):512-21. PubMed ID: 7830734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.